$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The latest domestic price and buying guide of ixazomib in 2024
2026-02-01 22:25:32
Check Details
What side effects may ixazomib cause during treatment, and how should patients deal with these adverse reactions?
2026-02-01 22:25:32
Check Details
Ixazomib: What kind of drug is this? What are the mechanisms of action and indications?
2026-02-01 22:25:32
Check Details
Is Platinib effective in treating medullary thyroid cancer?
2026-02-01 22:25:32
Check Details
Is Platinib good for clinical treatment of liver cancer?
2026-02-01 22:25:32
Check Details
Are prexitinib and platinib the same medicine?
2026-02-01 22:25:32
Check Details
Side effects and related matters that patients with lung cancer need to pay attention to when using platinib
2026-02-01 22:25:32
Check Details
How long can I take Platinib?
2026-02-01 22:25:32
Check Details
How long will the effects of Platinib last?
2026-02-01 22:25:32
Check Details
Is it normal to have no adverse reactions when taking Platinib?
2026-02-01 22:25:32
Check Details
Correct usage and dosage of Platinib
2026-02-01 22:25:32
Check Details
First-line acotinib/acabrutinib plus chemoimmunotherapy improves PFS in elderly patients with MCL
2026-02-01 22:25:32
Check Details
1
2
...
854
855
856
857
858
859
860
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
2
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
3
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
4
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
5
User Agreement
6
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
7
What is the most important information I should know about WELIREG?
8
How to take and store WELIREG
9
How to take TRUSELTIQ correctly
10
How to deal with LONSURF side effects (1)
11
How to deal with LONSURF side effects (2)
12
Cabozantinib (Cabometyx)-new indication approved